La Jolla teams with Stanford U. for delivery tech; EastGate, Toronto Western develop seizure spray;

> La Jolla Pharmaceutical Company ($LJPC) joined forces with Stanford University to develop delivery technology for its rare-disease pipeline. Release

> EastGate Acquisitions is collaborating with a neuorologist at Toronto Western Hospital, Peter Carlen, to help develop an intraoral lorazepam spray for treating acute and repetitive seizures. Release

> A low dose of the drug bortezomib helps oncolytic viruses kill cancer cells. Announcement

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.